RAPT Therapeutics (RAPT) shares rose 16% in recent Thursday trading after HC Wainwright upgraded its rating on the stock to buy from neutral with a price target of $10.
Intraday volume topped 8.2 million shares versus the daily average of 2.92 million.
Price: 2.01, Change: +0.28, Percent Change: +16.19